HCP engagements are an integral part of life sciences commercial strategy and must be conducted in an engaging and compliant manner. With the COVID-19 impact, both Top-10 Pharma and emerging Biotech companies have had to shift all meetings to a virtual approach with minimal notice, globally.
In this webinar, Michael Utell, General Manager, IQVIA Commercial Compliance, Dario Ghoddousi, Senior Director, Compliance and Quality, IQVIA and Staci Hutchinson, Director, Global Client Services, at IQVIA will share the key steps that must be taken to ensure effective engagements and business continuity, when transitioning from live to virtual. Join us as these experts discuss the strategies the Commercial Compliance team leveraged to transition all customers to a virtual meetings approach within a one-month period. Discover the technology considerations, GDPR concerns to address, and best practices to incorporate to deliver both impactful and compliant virtual engagements.
For more information or to register click here.